Heart Test Laboratories Inc. (HSCS): Net earnings per share (EPS TTM)

Symbol and logo of brand Heart Test Laboratories (HSCS)

The clinical validation of the Heart Test Laboratories (HSCS) AI platform is creating the primary growth impulse. The TTM annual earnings per share trend on the GURU.Markets chart, where the value -3.22 reflects the current figure, links the trend to fundamentals. The brand is valued for its precision in diagnosing hidden pathologies, while revenue is based on the implementation of cloud software and intelligent ECG systems.

HSCS Heart Test Labs Net earnings per share for the last four quarters (04/28/2023 - 11/10/2026)

Analytical breakdowns and data insights for company Heart Test Laboratories, Inc. (HSCS)

- current quotes and average value forecast:
Price Chart Heart Test Laboratories|HSCS - Analyst Median Target
- stock exchange capitalization data:
Market Capitalization Heart Test Laboratories|HSCS - Company Buyout Price
- business book valuation details:
Net Assets per Single Share HeartSciences|HSCS - Book Valuation of Business|Market Capitalization to Book Value Ratio heartsciences.com|HSCS - Aggregate Asset Value
- issuer credit burden and liquidity indicators:
Total Debt to Capital Heart Test Laboratories|HSCS - Long-Term Liabilities to Capital|Short-Term Debt to Capital Heart Test Laboratories Inc.|HSCS - Company Aggregate Debts|Debt to Book Capitalization Ratio Heart Test Laboratories|HSCS - Company Long-Term Loans and Borrowings|Company Current Liabilities HeartSciences|Quick Liquidity Indicator heartsciences.com
- earnings and multiples data:
HSCS - Final Profit|Future Profit Heart Test Laboratories|HSCS - Market Price to Net Income Ratio|Forward P/E Multiple HeartSciences|HSCS - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Heart Test Laboratories|HSCS - Operating income before deduction of amortization|Net earnings per share for the last 12 months HeartSciences|HSCS - Earnings per share for the last four quarters|Year-over-year net earnings per share growth for the last 12 months heartsciences.com|HSCS - Earnings per share increase in current year|Net earnings per share growth forecast for next year Heart Test Laboratories
Analysis of all company metrics:HSCS - Heart Test Laboratories
Manufactured products of Heart Test Laboratories, Inc.

To minimize speculative risks, investors must separate market noise from actual business profitability. This metric is calculated as the ratio of net income to the total number of shares outstanding over the last 12 months. By analyzing the trailing twelve-month (TTM) earnings per share, one can assess the stability of fundamental income. For Heart Test Laboratories (HSCS), this trend confirms the effectiveness of the transition to a subscription model. The growth of this indicator signals the successful monetization of a narrow AI diagnostics niche.

Competing companies

A - Earnings per share for the last twelve months|Net earnings per share for the last four quarters questdiagnostics.com DGX|ILMN: Net earnings per share (EPS TTM)|EXAS - Net earnings per share for the last four quarters|Earnings per share for the last twelve months PerkinElmer|Bio-Rad Corp (BIO) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) NNNN|SHC (soterahealth.com) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) QDEL (QuidelOrtho Corporation)|OPKO Health Inc (OPK) - Net earnings per one share for the last twelve months|CareDx Health - Net earnings per share (EPS TTM)|MRVI - Net earnings per share (EPS TTM)|Fulgent Genetics, Inc. (FLGT) - Earnings per share for the last twelve months|fluidigm.com - Earnings per share for the trailing year|Net earnings per share for the last 12 months CTKB|OSUR (OraSure Technologies, Inc.) - Earnings per share for the last four quarters|Net earnings per share for the last 12 months XGN (Exagen Inc.)|MDXH (MDxHealth, Inc.) - Earnings per share for the trailing year|Lucid Diagnostics Inc. - Net earnings per share for the last 12 months|Earnings per share for the last four quarters PRE (Prenetics Global Limited)|Insight Molecular - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Trinity Biotech plc|ProPhase (PRPH) - Earnings per share for the last twelve months|AIMD - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months CODX|BMRA (biomerica.com) - Earnings per share for the last four quarters|Net earnings per share for the last 12 months CDIO (Cardio Diagnostics)|ONCO (Onconetix Inc) - Earnings per share for the trailing year|Earnings per share for the last twelve months Virax Biolabs Group Ltd VRAX|Bluejay Diagnostics Corp - Earnings per share for the last twelve months|Aspira Women's Health - Net earnings per share (EPS TTM)|AXDX - Net earnings per share (EPS TTM)|CNTG: Net earnings per share (EPS TTM)|ENZ (Enzo Biochem) - Earnings per share for the last twelve months|Earnings per share for the last twelve months Fresh2 Group Ltd|Net earnings per one share for the last twelve months GTG Labs GENE|Earnings per share for the last twelve months 23andMe Holding Co. (ME)|PMD (psychemedics.com) - Earnings per share for the trailing year